Booster Vaccine Doses
- All
- News
- Videos
-
"Wish I Hadn't": US Anchor Megyn Kelly's Big Claim On Pfizer Covid Vaccine
American journalist Megyn Kelly has claimed that she developed an "autoimmune condition" after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021.
-
Top 5 Vaccine Recommendations For A Healthy 50's
Let's delve into the top five vaccine recommendations that every individual in their 50s should consider to stay fit, strong, and resilient.
-
"Cure Can't Be Worse...": Elon Musk Claims Covid Booster Dose Almost Sent Him To Hospital
Billionaire Elon Musk on Tuesday claimed that his Covid vaccine shot almost sent him to the hospital.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Smartwatch Data Shows COVID Booster Dose Safe for Heart: Lancet Study
The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.
-
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres
-
Can't Take Nasal Vaccine After Booster: Covid Task Force Chief To NDTV
India's nasal vaccine cannot be administered to those who have taken a precaution or booster dose, the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
India's Intranasal Covid Vaccine Is Here. Can Be Availed On COWIN Platform
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening, official sources said.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
"Wish I Hadn't": US Anchor Megyn Kelly's Big Claim On Pfizer Covid Vaccine
American journalist Megyn Kelly has claimed that she developed an "autoimmune condition" after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021.
-
Top 5 Vaccine Recommendations For A Healthy 50's
Let's delve into the top five vaccine recommendations that every individual in their 50s should consider to stay fit, strong, and resilient.
-
"Cure Can't Be Worse...": Elon Musk Claims Covid Booster Dose Almost Sent Him To Hospital
Billionaire Elon Musk on Tuesday claimed that his Covid vaccine shot almost sent him to the hospital.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Smartwatch Data Shows COVID Booster Dose Safe for Heart: Lancet Study
The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.
-
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres
-
Can't Take Nasal Vaccine After Booster: Covid Task Force Chief To NDTV
India's nasal vaccine cannot be administered to those who have taken a precaution or booster dose, the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
India's Intranasal Covid Vaccine Is Here. Can Be Availed On COWIN Platform
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening, official sources said.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
